Cargando…
St Gallen molecular subtypes in screening‐detected and symptomatic breast cancer in a prospective cohort with long‐term follow‐up
BACKGROUND: Diagnosis by screening mammography is considered an independent positive prognostic factor, although the data are not fully in agreement. The aim of the study was to explore whether the mode of detection (screening‐detected versus symptomatic) adds prognostic information to the St Gallen...
Autores principales: | Falck, A. K., Röme, A., Fernö, M., Olsson, H., Chebil, G., Bendahl, P. O., Rydén, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067683/ https://www.ncbi.nlm.nih.gov/pubmed/26856820 http://dx.doi.org/10.1002/bjs.10070 |
Ejemplares similares
-
St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial
por: Falck, Anna-Karin, et al.
Publicado: (2013) -
St Gallen 2019 guidelines understage the axilla in lobular breast cancer: a population-based study
por: Narbe, U, et al.
Publicado: (2021) -
The 14th European Colorectal Congress (#ECCStGallen), 29 November–2 December 2020, St. Gallen, Switzerland
por: Adamina, M., et al.
Publicado: (2021) -
The 13th European Colorectal Congress (#ECCStGallen), 1–5 December 2019, St Gallen, Switzerland: Congress Report
por: Adamina, M., et al.
Publicado: (2020) -
PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
por: Lundgren, Christine, et al.
Publicado: (2022)